Advertisement

Picture EBD Group BIO-Europe Spring 2025 Milan to 28 Feb 650x100px
Organisation › Details

MIG Capital AG

MIG Capital is one of the leading German VC investors. MIG invests in young deep tech and life sciences companies in German-speaking Europe and beyond. The company has so far invested over €680 million in about 50 companies. MIG's portfolio companies develop innovations in areas such as biopharmaceuticals, energy and environmental technologies, advanced computing, digitization / IoT, medical technology and digital health. The MIG investment portfolio currently comprises 30 companies. MIG’s investment team consists of a committed group of experts of engineers, biologists, scientists and investors who use analytical and creative processes to evaluate the risks and opportunities of business models and technologies. Their reputation, experience and network provide excellent access to companies, institutions and decision-makers in order to support the growth of their portfolio companies. In recent years, MIG Capital realized more than ten successful sales, including more recently the portfolio companies Siltectra (to Infineon, 2018) and Hemovent (MicroPort, 2021), and led BRAIN (in 2017), NFON (in 2018), BioNTech (in 2019) and Immatics (in 2020) to listings on stock exchanges. *

 

Period Start 2021-11-01 existent
  Group MIG Fonds (Group)
Products Industry venture capital
  Industry 2 LIFE SCIENCES
Persons Person Motschmann, Michael (MIG Funds 200604)
  Person 2 Kromayer, Matthias (MIG Funds 201009)
     
Region Region München (Munich)
  Country Germany
  Street 102 Ismaninger Str.
  City 81675 München
    Address record changed: 2024-01-05
     
Basic data Employees n. a.
     
    * Document for »About Section«: Mbiomics GmbH. (3/23/23). "Press Release: Microbiome Therapeutics Biotech Mbiomics Raises EUR 13 Million in First Closing of Series A Round". Munich.
     
   
Record changed: 2024-12-29

Advertisement

Picture Berlin Partner Events Bionnale 2025 May HealthCapital 650x200px

More documents for MIG Fonds (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Swiss Biotech Association LSE Swiss Biotech Days 2025 Basel 650x300px




» top